|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
279:23327-23334
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations.
|
|
J.J.Dumas,
R.Kumar,
T.McDonagh,
F.Sullivan,
M.L.Stahl,
W.S.Somers,
L.Mosyak.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The adhesion of platelets to the subendothelium of blood vessels at sites of
vascular injury under high shear conditions is mediated by a direct interaction
between the platelet receptor glycoprotein Ibalpha (GpIbalpha) and the A1 domain
of the von Willebrand factor (VWF). Here we report the 2.6-A crystal structure
of a complex comprised of the extracellular domain of GpIbalpha and the
wild-type A1 domain of VWF. A direct comparison of this structure to a
GpIbalpha-A1 complex containing "gain-of-function" mutations, A1-R543Q
and GpIbalpha-M239V, reveals specific structural differences between these
complexes at sites near the two GpIbalpha-A1 binding interfaces. At the smaller
interface, differences in interaction show that the alpha1-beta2 loop of A1
serves as a conformational switch, alternating between an open alpha1-beta2
isomer that allows faster dissociation of GpIbalpha-A1, as observed in the
wild-type complex, and an extended isomer that favors tight association as seen
in the complex containing A1 with a type 2B von Willebrand Disease (VWD)
mutation associated with spontaneous binding to GpIbalpha. At the larger
interface, differences in interaction associated with the GpIbalpha-M239V
platelet-type VWD mutation are minor and localized but feature discrete
gamma-turn conformers at the loop end of the beta-hairpin structure. The
beta-hairpin, stabilized by a strong classic gamma-turn as seen in the mutant
complex, relates to the increased affinity of A1 binding, and the beta-hairpin
with a weak inverse gamma-turn observed in the wild-type complex corresponds to
the lower affinity state of GpIbalpha. These findings provide important details
that add to our understanding of how both type 2B and platelet-type VWD
mutations affect GpIbalpha-A1 binding affinity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
FIG. 2. Superposition of GpIb -A1 and GpIb -M239V/A1-R543Q
complexes. The GpIb is green, and the GpIb
-bound wild-type A1
domain is gold. Regions of GpIb -M239V that differ most
extensively from wild-type A1 are red ( -switch region,
Val227-Ser241; cysteine loop, Asp249-Phe^254) and the remainder
of the molecule is white. The region of A1-R543Q with the most
notable change in conformation compared with the wild-type A1
structure is blue ( 1- 2 loop, Arg543-Arg552),
and the remainder of A1 is white. The structure of mutant
complex is derived from PDB code 1M10 [PDB]
(35).
|
 |
Figure 5.
FIG. 5. Superposition of unliganded A1, wild-type GpIb -A1 and
GpIb -M239V-A1-R543Q.
Rearrangement of the 1- 2 loop region of A1 is
highlighted. The 1- 2 loop region of
unliganded A1 (33)(shown in purple) adopts an intermediate
conformation between the closed conformation of 1- 2 in the
mutant complex (blue) and the open conformation of 1- 2 in the
wild-type complex (gold).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
23327-23334)
copyright 2004.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.C.Berndt,
and
R.K.Andrews
(2011).
Thrombotic thrombocytopenic purpura: reducing the risk?
|
| |
J Clin Invest,
121,
522-524.
|
 |
|
|
|
|
 |
M.Landau,
and
N.Rosenberg
(2011).
Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders.
|
| |
Transfusion,
51,
558-569.
|
 |
|
|
|
|
 |
C.Ravanat,
C.Strassel,
B.Hechler,
S.Schuhler,
G.Chicanne,
B.Payrastre,
C.Gachet,
and
F.Lanza
(2010).
A central role of GPIb-IX in the procoagulant function of platelets that is independent of the 45-kDa GPIbalpha N-terminal extracellular domain.
|
| |
Blood,
116,
1157-1164.
|
 |
|
|
|
|
 |
E.E.Gardiner,
J.F.Arthur,
Y.Shen,
D.Karunakaran,
L.A.Moore,
J.S.Am Esch,
R.K.Andrews,
and
M.C.Berndt
(2010).
GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.
|
| |
Platelets,
21,
244-252.
|
 |
|
|
|
|
 |
J.Kim,
C.Z.Zhang,
X.Zhang,
and
T.A.Springer
(2010).
A mechanically stabilized receptor-ligand flex-bond important in the vasculature.
|
| |
Nature,
466,
992-995.
|
 |
|
|
|
|
 |
P.Nurden,
G.Gobbi,
A.Nurden,
J.Enouf,
I.Youlyouz-Marfak,
C.Carubbi,
S.La Marca,
M.Punzo,
L.Baronciani,
L.De Marco,
M.Vitale,
and
A.B.Federici
(2010).
Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B.
|
| |
Blood,
115,
2649-2656.
|
 |
|
|
|
|
 |
R.P.McEver,
and
C.Zhu
(2010).
Rolling cell adhesion.
|
| |
Annu Rev Cell Dev Biol,
26,
363-396.
|
 |
|
|
|
|
 |
T.Thijs,
B.P.Nuyttens,
H.Deckmyn,
and
K.Broos
(2010).
Platelet physiology and antiplatelet agents.
|
| |
Clin Chem Lab Med,
48,
S3-13.
|
 |
|
|
|
|
 |
A.B.Herr,
and
R.W.Farndale
(2009).
Structural insights into the interactions between platelet receptors and fibrillar collagen.
|
| |
J Biol Chem,
284,
19781-19785.
|
 |
|
|
|
|
 |
A.T.Nurden,
A.B.Federici,
and
P.Nurden
(2009).
Altered megakaryocytopoiesis in von Willebrand type 2B disease.
|
| |
J Thromb Haemost,
7,
277-281.
|
 |
|
|
|
|
 |
J.L.Diener,
H.A.Daniel Lagassé,
D.Duerschmied,
Y.Merhi,
J.F.Tanguay,
R.Hutabarat,
J.Gilbert,
D.D.Wagner,
and
R.Schaub
(2009).
Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779.
|
| |
J Thromb Haemost,
7,
1155-1162.
|
 |
|
|
|
|
 |
K.L.Hindle,
J.Bella,
and
S.C.Lovell
(2009).
Quantitative analysis and prediction of curvature in leucine-rich repeat proteins.
|
| |
Proteins,
77,
342-358.
|
 |
|
|
|
|
 |
M.Auton,
E.Sedlák,
J.Marek,
T.Wu,
C.Zhu,
and
M.A.Cruz
(2009).
Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha.
|
| |
Biophys J,
97,
618-627.
|
 |
|
|
|
|
 |
M.Baud'huin,
L.Duplomb,
S.Téletchéa,
C.Charrier,
M.Maillasson,
M.Fouassier,
and
D.Heymann
(2009).
Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.
|
| |
J Biol Chem,
284,
31704-31713.
|
 |
|
|
|
|
 |
R.H.Huang,
D.H.Fremont,
J.L.Diener,
R.G.Schaub,
and
J.E.Sadler
(2009).
A structural explanation for the antithrombotic activity of ARC1172, a DNA aptamer that binds von Willebrand factor domain A1.
|
| |
Structure,
17,
1476-1484.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.E.Thomas
(2009).
Mechanochemistry of receptor-ligand bonds.
|
| |
Curr Opin Struct Biol,
19,
50-55.
|
 |
|
|
|
|
 |
Z.M.Ruggeri
(2009).
Platelet adhesion under flow.
|
| |
Microcirculation,
16,
58-83.
|
 |
|
|
|
|
 |
J.Chen,
K.Tan,
H.Zhou,
H.F.Lo,
D.T.Roux,
R.C.Liddington,
and
T.G.Diacovo
(2008).
Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies.
|
| |
Nat Biotechnol,
26,
114-119.
|
 |
|
|
|
|
 |
J.Lou,
and
C.Zhu
(2008).
Flow induces loop-to-beta-hairpin transition on the beta-switch of platelet glycoprotein Ib alpha.
|
| |
Proc Natl Acad Sci U S A,
105,
13847-13852.
|
 |
|
|
|
|
 |
N.A.Mody,
and
M.R.King
(2008).
Platelet adhesive dynamics. Part II: high shear-induced transient aggregation via GPIbalpha-vWF-GPIbalpha bridging.
|
| |
Biophys J,
95,
2556-2574.
|
 |
|
|
|
|
 |
Q.R.Fan,
and
W.A.Hendrickson
(2008).
Comparative structural analysis of the binding domain of follicle stimulating hormone receptor.
|
| |
Proteins,
72,
393-401.
|
 |
|
|
|
|
 |
R.K.Andrews,
and
M.C.Berndt
(2008).
Platelet adhesion: a game of catch and release.
|
| |
J Clin Invest,
118,
3009-3011.
|
 |
|
|
|
|
 |
T.Yago,
J.Lou,
T.Wu,
J.Yang,
J.J.Miner,
L.Coburn,
J.A.López,
M.A.Cruz,
J.F.Dong,
L.V.McIntire,
R.P.McEver,
and
C.Zhu
(2008).
Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
|
| |
J Clin Invest,
118,
3195-3207.
|
 |
|
|
|
|
 |
Z.Chen,
J.Lou,
C.Zhu,
and
K.Schulten
(2008).
Flow-induced structural transition in the beta-switch region of glycoprotein Ib.
|
| |
Biophys J,
95,
1303-1313.
|
 |
|
|
|
|
 |
N.Matsushima,
T.Tanaka,
P.Enkhbayar,
T.Mikami,
M.Taga,
K.Yamada,
and
Y.Kuroki
(2007).
Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors.
|
| |
BMC Genomics,
8,
124.
|
 |
|
|
|
|
 |
N.Rosenberg,
S.Lalezari,
M.Landau,
B.Shenkman,
U.Seligsohn,
and
S.Izraeli
(2007).
Trp207Gly in platelet glycoprotein Ibalpha is a novel mutation that disrupts the connection between the leucine-rich repeat domain and the disulfide loop structure and causes Bernard-Soulier syndrome.
|
| |
J Thromb Haemost,
5,
378-386.
|
 |
|
|
|
|
 |
Q.R.Fan,
and
W.A.Hendrickson
(2007).
Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor.
|
| |
Mol Cell Endocrinol,
260,
73-82.
|
 |
|
|
|
|
 |
A.T.Nurden,
and
P.Nurden
(2006).
Inherited disorders of platelets: an update.
|
| |
Curr Opin Hematol,
13,
157-162.
|
 |
|
|
|
|
 |
L.D.Morales,
C.Martin,
and
M.A.Cruz
(2006).
The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen.
|
| |
J Thromb Haemost,
4,
417-425.
|
 |
|
|
|
|
 |
S.Kunishima,
T.Imai,
M.Hamaguchi,
and
H.Saito
(2006).
Novel heterozygous missense mutation in the second leucine rich repeat of GPIbalpha affects GPIb/IX/V expression and results in macrothrombocytopenia in a patient initially misdiagnosed with idiopathic thrombocytopenic purpura.
|
| |
Eur J Haematol,
76,
348-355.
|
 |
|
|
|
|
 |
T.A.Springer
(2006).
Complement and the multifaceted functions of VWA and integrin I domains.
|
| |
Structure,
14,
1611-1616.
|
 |
|
|
|
|
 |
V.M.Chen,
and
P.J.Hogg
(2006).
Allosteric disulfide bonds in thrombosis and thrombolysis.
|
| |
J Thromb Haemost,
4,
2533-2541.
|
 |
|
|
|
|
 |
A.T.Nurden
(2005).
Qualitative disorders of platelets and megakaryocytes.
|
| |
J Thromb Haemost,
3,
1773-1782.
|
 |
|
|
|
|
 |
K.Fukuda,
T.Doggett,
I.J.Laurenzi,
R.C.Liddington,
and
T.G.Diacovo
(2005).
The snake venom protein botrocetin acts as a biological brace to promote dysfunctional platelet aggregation.
|
| |
Nat Struct Mol Biol,
12,
152-159.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |